Bristol-Myers Squibb (BMY)/Celgene (CELG) Merger Spread Continues to Narrow

March 14, 2019 11:03 AM

Bristol-Myers Squibb (NYSE: BMY) and Celgene (NASDAQ: CELG) deal spread continues to narrow. Last 13.1% after being as high as 22.3%.

Categories

Mergers and Acquisitions Trader Talk